CD14 and rheumatoid arthritis: We quantified the percentage of classic CD14+CD16- monocytes, intermediate CD14+CD16+ monocytes, and nonclassic CD14dimCD16+ monocytes [32] in peripheral blood from SpA and RA patients and healthy donors, and did not observe differences in these monocyte subsets between the groups (Figure 2A).